Increased expression of scavenger receptor type I gene in human peripheral blood from hyperlipidemic patients determined by quantitative additive RT-PCR

被引:14
作者
Villanova, JG [1 ]
Lucena, JLD [1 ]
Arcas, NF [1 ]
Engel, AR [1 ]
机构
[1] UNIV MALAGA,FAC MED,DEPT BIOCHEM & MOLEC BIOL,E-29080 MALAGA,SPAIN
来源
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM | 1996年 / 1300卷 / 02期
关键词
macrophage; monocyte; hyperlipidemia; atherosclerosis; scavenger receptor;
D O I
10.1016/0005-2760(96)00008-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The scavenger receptors type I and II are mediators for the binding and uptake of chemically modified lipoproteins and are restricted to cells of monocyte origin. These receptors are highly expressed during the process of monocyte to macrophage differentiation. Quantitative mRNA levels of scavenger receptors from peripheral blood mononuclear cells have been analyzed in 29 hyperlipidemic patients and 15 healthy controls. Macrophage scavenger receptor isoforms transcripts were studied in circulating peripheral blood mononuclear cells with a modified RT-PCR method based on the use of a non-modified internal standard and a mathematical logistic adjustment of the standard curve. This method makes it feasible to study the variation in the expression of the scavenger receptors gene in peripheral blood during different physiopathological conditions. We studied the expression of the scavenger receptors gene in different blood cell lines and was present in only those of monocytic origin. The results have shown evidence that levels of scavenger receptor type I transcripts were proportional to apoB/cholesterol levels whereas type II receptors did not show any transcriptional variability. These findings suggest that the cholesterol level exerts a selective up-regulation of the scavenger receptor type I which is detectable by the induced increment of circulating monocytes in the blood of hyperlipidemic patients.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 41 条
[1]   MONOCYTIC ORIGIN OF FOAM CELLS IN HUMAN ATHEROSCLEROTIC PLAQUES [J].
AQEL, NM ;
BALL, RY ;
WALDMANN, H ;
MITCHINSON, MJ .
ATHEROSCLEROSIS, 1984, 53 (03) :265-271
[2]  
AVERILL LE, 1989, AM J PATHOL, V135, P369
[3]  
BEPPU M, 1994, BIOL PHARM BULL, V17, P39, DOI 10.1248/bpb.17.39
[4]   HIV TYPE-2 PROVIRAL LOAD MEASURED BY QUANTITATIVE POLYMERASE CHAIN-REACTION CORRELATES WITH CD4+ LYMPHOPENIA IN HIV TYPE 2-INFECTED INDIVIDUALS [J].
BERRY, N ;
ARIYOSHI, K ;
JOBE, O ;
NGUM, PT ;
CORRAH, T ;
WILKINS, A ;
WHITTLE, H ;
TEDDER, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (08) :1031-1037
[5]   LIPOPROTEIN METABOLISM IN THE MACROPHAGE - IMPLICATIONS FOR CHOLESTEROL DEPOSITION IN ATHEROSCLEROSIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 :223-261
[6]   LOW-DENSITY LIPOPROTEIN RECEPTOR ACTIVITY IN CULTURED HUMAN-SKIN FIBROBLASTS - MECHANISM OF INSULIN-INDUCED STIMULATION [J].
CHAIT, A ;
BIERMAN, EL ;
ALBERS, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (05) :1309-1319
[7]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[8]   MACROPHAGE-COLONY-STIMULATING FACTOR SELECTIVELY ENHANCES MACROPHAGE SCAVENGER RECEPTOR EXPRESSION AND FUNCTION [J].
DEVILLIERS, WJS ;
FRASER, IP ;
HUGHES, DA ;
DOYLE, AG ;
GORDON, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :705-709
[9]  
DIAMOND JR, 1989, AM J PATHOL, V135, P711
[10]   PATHOLOGY OF ATHEROSCLEROSIS [J].
DUFF, GL ;
MCMILLAN, GC .
AMERICAN JOURNAL OF MEDICINE, 1951, 11 (01) :92-108